In a shift away from next-generation Covid-19 vaccines, the Trump administration is investing $500 million in a vaccine ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...

The potential change outlined in a statement would require all new vaccines to undergo “placebo” testing, sparking concerns ...

A Cleveland Clinic web page describing myocarditis survival rates was misrepresented online as news that millions who received COVID-19 vaccines were about to die.

Notes from a recent meeting of the CDC’s Advisory Committee on Immunization Practices’ COVID-19 Work Group show health ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Pfizer Inc. and BioNTech SE failed to knock out any of Alnylam Pharmaceuticals Inc.’s patents in a case over the partners’ ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

A pharmacy in New York City advertises the coronavirus vaccine on March 11. (Spencer Platt/Getty Images) The Centers for Disease Control and Prevention might soon limit its guidance for who should ...